Glenning Robert 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Mar 9, 2023
Insider Transaction Report
Form 4
Glenning Robert
Director
Transactions
- Award
Stock Option (right to buy)
2023-03-07+16,253→ 16,253 totalExercise: $26.00Exp: 2033-03-07→ Common Stock (16,253 underlying)
Footnotes (1)
- [F1]The option fully vests on March 7, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.